Cmpx stock forecast.
Jul 11, 2023 · CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.
CMPX: Compass Therapeutics, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Compass Therapeutics, Inc. from Zacks Investment ResearchTrack COMPASS Pathways (CMPS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors FORECASTS Analyst Sentiment LeaderboardPrevious Close $3.68. Volume 32.29K. Average Volume (3M) 157.25K. Market Cap. $1.22B. Enterprise Value $963.30M. Total Cash (Recent Filing) $259.49M. Total Debt (Recent Filing) $921.00K. Price to Earnings (P/E) -5.0.
Previous Close $3.68. Volume 32.29K. Average Volume (3M) 157.25K. Market Cap. $1.22B. Enterprise Value $963.30M. Total Cash (Recent Filing) $259.49M. Total Debt (Recent Filing) $921.00K. Price to Earnings (P/E) -5.0.Ford pegged the cost of the six-week UAW strikes at $1.7 billion, more than rival GM's $1.1 billion estimate, while issuing an updated 2023 profit forecast. By Martin Baccardax STOCKSData Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...
BOSTON, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer ...
Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Stock Market Today: Stocks extend gains as investors ignore Powell warning on rates. Investors are heading into the final month of the year on solid footing, with an 18.5% gain for the S&P 500 and ...Complix' Alphabody™ Protein Therapeutics Demonstrate Activity against both Undruggable Extracellular and Intracellular Disease TargetsCheck if CMPS Stock has a Buy or Sell Evaluation. CMPS Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Compass Pathways PLC News.
The average Albemarle stock price prediction forecasts a potential upside of 66.63% from the current ALB share price of $121.27. What is ALB's forecast return on equity (ROE) for 2023-2026? (NYSE: ALB) forecast ROE is N/A, which is considered weak.
FORECASTS Analyst Sentiment Leaderboard
Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ... Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ...Research CompX International's (NYSEAM:CIX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener. Stocks / Commercial Services; CompX International NYSEAM:CIX Stock Report. Last Price. US$21.81. …Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary. Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST...
The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.BHC Stock 12 Months Forecast. $9.00. (30.72% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $9.00 with a high forecast of $16.00 and a low forecast of $6.00. The average price target represents a 30.72% change from the last price of $6.89.Compass pointing South. CMPX We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statisti We are not in the business of getting …What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system. Find the latest performance data chart, historical data and news for NASDAQ Composite Index (COMP) at Nasdaq.com.
Nov 18, 2023 · It follows that stock’s current price would drop -591.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -403.14% for stock’s current value. Compass Therapeutics Inc (CMPX) estimates and forecasts Source: YCharts. Management said during the company's 2022 investor day in June last year that it expects long-term annual revenue growth of 20%. Assuming AMD's top line grows at an annual pace of ...
The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ...Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ... The Meme Stock. C-Suite Advisors. Sign In. ... Nvidia earnings crush forecasts, outlook tops estimates, amid surging AI demand. By Martin Baccardax. Nov 21, 2023 5:00 PM EST. STOCKS. MSFT NVDA.Get the latest Cerner Corporation (CERN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary.Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million.
Dec 1, 2023 · The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low.
The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.
Our goal is to do fundamental research, invent new technology, and create frameworks for stock forecast.Accurate stock price prediction has an important role in stock investment. Because stock price data are characterized by high frequency, nonlinearity, and long memory, predicting stock prices precisely is challenging. Various forecasting methods have been proposed, from classical time series methods to machine-learning-based …Previous Close $3.68. Volume 32.29K. Average Volume (3M) 157.25K. Market Cap. $1.22B. Enterprise Value $963.30M. Total Cash (Recent Filing) $259.49M. Total Debt (Recent Filing) $921.00K. Price to Earnings (P/E) -5.0.The average Cabaletta Bio stock price prediction forecasts a potential upside of 75.22% from the current CABA share price of $18.67. What is CABA's forecast return on ...PSTX Stock 12 Months Forecast. $12.25. (369.35% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Poseida Therapeutics in the last 3 months. The average price target is $12.25 with a high forecast of $15.00 and a low forecast of $8.00. The average price target represents a 369.35% change from the last price of $2.61.WVE. Wave Life Sciences Ltd. 5.31. -0.09. -1.67%. In this article, we will take a look at the 11 best biotech penny stocks to buy now. To see more such companies, go directly to 5 Best Biotech ...SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ... 1.57%. $249.05M. CIX | Complete CompX International Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Get the latest news and real-time alerts from Compass Therapeutics, Inc. (CMPX) stock at Seeking Alpha. ... CMPX Compass Therapeutics, Inc. Latest News. Follow $1.93 0.00 (0.00%) ...
Nov 30, 2023 · The Compass Therapeutics, Inc. stock price gained 6.00% on the last trading day (Friday, 17th Nov 2023), rising from $1.50 to $1.59. During the last trading day the stock fluctuated 15.61% from a day low at $1.51 to a day high of $1.74. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period. Nov 8, 2023 · Predictions of CMPX stock price for tomorrow. Safe & Green Development Corp. $1.95. -0.70. -26.42%. COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information. Instagram:https://instagram. russell 3000 index fundhow to trade xsp optionsbest cash app stocks right nowbest energy companies to invest in The average price target for aTyr Pharma is $21.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $35.00 ,the lowest forecast is $12.00. The average price target represents 1785.96% Increase from the current price of $1.14.Stock price analysis for Compass Therapeutics, Inc. (CMPX), stock quote, stock research, rsi, macd, support, resistance and most important highlights. illumina stock forecastsusan b anthony coin worth 66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00. how much is banfield pet insurance A high-level overview of CompX International Inc. (CIX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.To get a sense of who is truly in control of Compass Therapeutics, Inc. (NASDAQ:CMPX), it is important to understand the ownership structure of the business. The group holding the most number of ...